Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echo: Vitamin E-creme for Stage 0 Dupuytren Disease
NCT06321991Phase 2Recruiting
- Sponsor
- UZ Leuven
- Start
- Feb 2024
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dupuytren contracture comparing Placebo with Vitamin E (2 arms). Primary endpoint: Downsizing of the largest nodule diameter at 1 year. Started Feb 2024; status: recruiting.
02
Drugs
vitamin e
03
Conditions
Dupuytren contracture
Beyond the preview
Go deeper on NCT06321991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06321991.